PS Ratio Chart

View PS Ratio for VALN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2021. Start Trial.
Date Value
September 09, 2026 3.542
September 08, 2026 3.632
September 04, 2026 3.653
September 03, 2026 3.743
September 02, 2026 3.775
September 01, 2026 3.484
August 31, 2026 3.340
August 28, 2026 3.409
August 27, 2026 3.478
August 26, 2026 3.550
August 25, 2026 3.595
August 24, 2026 3.579
August 21, 2026 3.690
August 20, 2026 3.616
August 19, 2026 3.627
August 18, 2026 3.643
August 17, 2026 3.743
August 14, 2026 3.780
August 13, 2026 2.996
August 12, 2026 2.943
August 11, 2026 2.964
August 10, 2026 2.810
August 07, 2026 2.810
August 06, 2026 2.746
August 05, 2026 2.773
Date Value
August 04, 2026 2.725
August 03, 2026 2.688
July 31, 2026 2.635
July 30, 2026 2.697
July 29, 2026 2.688
July 28, 2026 2.683
July 27, 2026 2.630
July 24, 2026 2.534
July 23, 2026 2.534
July 22, 2026 2.598
July 21, 2026 2.614
July 20, 2026 2.566
July 17, 2026 2.651
July 16, 2026 2.694
July 15, 2026 2.717
July 14, 2026 2.709
July 13, 2026 2.789
July 10, 2026 2.678
July 09, 2026 2.808
July 08, 2026 2.815
July 07, 2026 2.789
July 06, 2026 2.863
July 02, 2026 2.770
July 01, 2026 2.699
June 30, 2026 2.773

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Pfizer Inc. 2.465
Nicox SA 1.24
DBV Technologies SA --
Cellectis SA 5.663
Genfit SA 10.63

PS Ratio Related Metrics

PEG Ratio -0.0241
Price to Book Value 6.942
Price 6.79
Earnings Yield -30.84%
Market Cap 643.85M
PEGY Ratio -0.0241